Results 81 to 90 of about 11,492 (193)

Associations between metabolic dysfunction-associated fatty liver disease and carotid and femoral atherosclerosis: a population-based cross-sectional study

Lipids in Health and Disease
Background The associations between metabolic dysfunction-associated fatty liver disease (MAFLD) and its subtypes (diabetes mellitus [DM]-MAFLD, overweight [OW]-MAFLD, and lean MAFLD) with carotid and femoral atherosclerosis are not well understood in ...
Zhenzhen Li, Sisi Jiang, Ruotian Chen, Zihan Zhang, Lijun Zheng, Heng He, Ruimei Feng, Shanshan Du, Weihong Qiu, Weimin Ye   +9 more
doaj   +1 more source

Associations of Metabolic Dysfunction–Associated Fatty Liver Disease With Peripheral Artery Disease: Prospective Analysis in the UK Biobank and ARIC Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background There is currently limited evidence comparing the association between metabolic dysfunction–associated fatty liver disease (MAFLD), nonalcoholic fatty liver disease (NAFLD), and the risk of peripheral artery disease (PAD).
YueRuiJing Liu, JinQi Wang, Rui Jin, ZongKai Xu, XiaoYu Zhao, YunFei Li, YanChen Zhao, ZhiYuan Wu, XiuHua Guo, LiXin Tao   +9 more
doaj   +1 more source

m6A‐Mediated Glycolysis by IL‐37 Drives T Cell Metabolic Reprogramming to Regulate Colitis

Advanced Science, Volume 13, Issue 49, 3 September 2026.
This study identifies an IL‐37/SIGIRR‐METTL14 regulatory axis that suppresses global m6A modification in CD4+ T cells. IL‐37 signaling, mediated through SIGIRR, inhibits IRAK4 and JNK phosphorylation, leading to downregulation of the methyltransferase METTL14.
Xiaoyan Wang, Jiadong Yu, Guolin Li, Ya Li, Fanlian Zeng, Jing Hu, Yifan Zhou, Chengcheng Yue, Qixiang Zhao, Chen Zhang, Hong Zhou, Fulei Zhao, Yawen Hu, Pei Zhou, Linna Gu, Yuting Feng, Mingxiang He, Shishi Huang, Xiaochi Sun, Xinmeng Wang, Jie Tang, Xinyu Zeng, Wenling Wu, Nongyu Huang, Xinai Cui, Kaijun Cui, Jiong Li   +26 more
wiley   +1 more source

MAFLD: Exploring the Systemic Effects Beyond Liver

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a growing global health concern which is driven by the increasing prevalence of diabetes and obesity.
Dayal, Utkarsh, Jain, Rohit, Kanagala, Sai Gautham, Munjal, Ripudaman S., Gupta, Vasu, Aggarwal, Kanishk, Bansal, Sourav, Kanagala, Sai G., Soni, Ujjwal, Chennupati, Chaitanya, Munjal, Ripudaman Singh   +10 more
core   +1 more source

Correlation between serum uric acid and body fat distribution in patients with MAFLD

, 2023
Background Metabolic dysfunction associated with fatty liver disease (MAFLD) is often correlated with obesity and hyperuricemia. The present study aimed to determine the association between serum uric acid (SUA) and central fat distribution in patients ...
Xingyu Chen, Jing Liu, Miao He, Cong Wang, Lili Zhang, Qing Wang, Wenwen Chen, Min Tao   +7 more
core   +1 more source

Comparative association between NAFLD and MAFLD with cardiovascular events and mortality: Evidence from observational studies.

PLoS ONE
BackgroundNonalcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated fatty liver disease (MAFLD) are increasingly recognized as multisystemic conditions with significant extrahepatic manifestations.
Taoli Fu, Jitao Ling, Huilei Zhao, Kaixin Lin, You Deng, Miao Zhang, Xinrui Qi, Peng Yu, Weichun Lin, Xiao Liu   +9 more
doaj   +1 more source

Circadian Misalignment Rather Than Sleep Duration is Associated with MAFLD: A Population-Based Propensity Score-Matched Study

Nature and Science of Sleep, 2021
Zhiyuan Weng,1 Weijie Ou,2 Jiaofeng Huang,2 Medha Singh,3 Mingfang Wang,2 Yueyong Zhu,2 Rahul Kumar,4,* Su Lin2,* 1Cardiology Department, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350001, People’s Republic of China;
Weng Z, Ou W, Huang J, Singh M, Wang M, Zhu Y, Kumar R, Lin S   +7 more
doaj  

Cancer Risk Among Young Adults With Clinically Diagnosed Fatty Liver Disease: A Nationwide Cohort Study in South Korea

Cancer Medicine, Volume 15, Issue 9, September 2026.
ABSTRACT Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a growing public health concern, particularly among young adults. While MASLD is a well‐established risk factor for liver‐related complications, growing evidence suggests an association with several extrahepatic cancers.
Sun Ju Lee, Yongho Jee, Ho Soo Chun, Hyun‐Young Shin   +3 more
wiley   +1 more source

Effect of MAFLD on albuminuria and the interaction between MAFLD and diabetes on albuminuria

Objective To investigate the effects of metabolic associated fatty liver disease (MAFLD) on chronic kidney disease (CKD) and abnormal albuminuria and the interaction between MAFLD and diabetes on abnormal albuminuria.
Xiaomei Zhang, Sanbao Chai, Yufang Liu
core   +1 more source

Correlation between MAFLD and DII

, 2023
Correlation between MAFLD and DIITHIS DATASET IS ARCHIVED AT DANS/EASY, BUT NOT ACCESSIBLE HERE.
jiang, C (via Mendeley Data)
core   +1 more source